The analysis of Nigeria's Domestic General Government Health Expenditure as a percentage of GDP from 2024 to 2028 highlights a consistent but slight decline. With the expenditure starting at 0.48% of GDP in 2024, it is projected to gradually decrease to 0.46% by 2028. Compared to 2023, the figure for 2024 signifies continuity if 2023 values are used as a constant.
The year-on-year percentage variations are minimal for each projected year, reflecting a stability in the expenditure as part of GDP. Over the last two years of projected data, there's a noticeable reduction, albeit small, and the five-year Compound Annual Growth Rate (CAGR) is negative, indicating a very slight annual decline in government health expenditure as a percentage of GDP.
Future trends to watch for:
- Implementation of new health policies that could alter government spending.
- Macro-economic changes that may impact GDP and, consequently, the % of it spent on health.
- Potential international aid or investment in Nigeria's health sector which may change the expenditure dynamics.
- Socio-political factors that may affect budget priorities and allocations to health expenditure.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...